California Diabetes Program: Providing Leadership, Promoting Quality, and Taking Action
Email this page
Print this Page   Extra Large Fonts You Are Currently Viewing Large Fonts Normal Font Size
The Mission of the California Diabetes Program is to prevent diabetes and its complications in California's diverse communities.
DIRC: The Diabetes Information Resource Center

 

 

 

 

California Medi-Cal Type 2 Diabetes Project

Date Activated: 07/21/2005 (Last Updated 04/11/2008)
Contributed By: California Diabetes Program
Author: Gary He, PhD

The MediCal Type 2 Diabetes Project assessed the impact of enhanced primary care plus case management on glycemic control and risk factors in MediCal recipients aged 18 yrs or older with type 2 diabetes. This project was a collaboration between by Harbor UCLA Medical Center, University of California, San Diego, Sansum Medical Research Institute, and the California Diabetes Program.  

Article Abstract

OBJECTIVE—Disparities exist in the diabetes health status of ethnic minority and/or low-income populations relative to other groups. A primary objective of diabetes management is to improve glycemic control. The feasibility of implementing intensive diabetes case management in disparate populations remains largely untested.

RESEARCH DESIGN AND METHODS—Clinical sites in three southern California counties serving low-income, ethnic minority populations participated in our study. We randomized 362 Medicaid (called Medi-Cal in California) recipients with type 2 diabetes for at least 1 year to intervention (diabetes case management) or control (traditional primary care treatment) groups. Fifty-five percent of participants were minorities. Participants with HbA1c levels less than 7.5%, serious diabetes-related complications, or other serious medical conditions were excluded. We assessed the effect of the intervention (ongoing diabetes case management added to primary care) on glycemic control using serial HbA1c measurements over several years.

RESULTS—The mean duration of follow-up was 25.3 months. HbA1c decreased substantially in both groups from an average of 9.54–7.66% (a reduction of 1.88%) in the intervention group and from an average of 9.66–8.53% (a reduction of 1.13%) in the control group. This improvement was sustained throughout the study. The reduction in HbA1c was consistently greater in the intervention group at each time point (P < 0.001), ranging between 0.65 at 6 months and 0.87 at study end.

CONCLUSIONS—Diabetes case management, added to primary care, substantially improved glycemic control compared with the control group. Diabetes case management can help reduce disparities in diabetes health status among low-income ethnic populations.

Reference: The California Medi-Cal Type 2 Diabetes Study Group. Closing the Gap: Effect of Diabetes Case Management on Glycemic Control Among Low-Income Ethnic Minority Populations. The California Medi-Cal Type 2 Diabetes Study. Diabetes Care 27:95-103, 2004

Download Files:

Click on a link below to save the file to your hard drive.

Evaluation:

This resource has been evaluated.

Details:
Baseline demographics, HbA1c, socioeconomic factors, ethnicity, and diabetes-related complications were similar in both groups. Mean duration of follow-up for patients included in analyses was 25.3 months. HbA1c decreased in both groups: 9.54% to 7.66% (Intervention), 9.66% to 8.53% (Conventional). In Intervention group: 1) HbA1c reduction was greater than in Conventional by 0.65% units at each time point (p < 0.0011); 2) use of diabetes medications increased (p = 0.01); and 3) LDL cholesterol decreased (p = 0.02).

California Department of Public Health | Diabetes Coalition of California | University of California, San Francisco

Major funding provided by the Division of Diabetes Translation, Centers for Disease Control and Prevention (CDC)

Important Disclaimer | Copyright Information | Privacy Statement | Submission Guidelines

Web Site Design and Development by David Levin